ARTTIC S.A.S.

ARTTIC assists clients from all business and research sectors, small and large, private and public, to ensure the success of their collaborative research & innovation ventures. During close to 32 years of success, ARTTIC developed and demonstrated expertise in the set-up and management of to date 400 large-scale ambitious projects of which 96 were successful under H2020 calls. Based on its long-standing experience in a range of funding programmes across scientific and technological domains, ARTTIC helps clients to move from strategic plans to effective competitive research and development of innovative solutions, resulting in successful applications and businesses. ARTTIC is a company of the PNO Consultants group, the European leader for consultancy in innovation and funding.

 

For more information, please visit our website.

 

Project Manager: Dr. Gabriele Wagner (Project Manager)

Project Leader: Dr. Claudia Pfander (Senior Consultant)

Axxam

Axxam SpA

AXXAM SpA is a privately owned innovative Partner Research Organization (iPRO) and discovery company located at OpenZone Science Park, Bresso (Milan, Italy), with chemistry laboratories located in Naples (Italy) and business development offices in Europe, US and Japan.

Since its inception in 2001, as a spin-off from the Bayer Group, Axxam has built up an integrated discovery “Lead Engine” platform, consisting of assay development, high throughput screening and hit follow-up activities and has supported the discovery programs of its clients by providing excellent quality discovery services carried out by highly engaged experts.

Axxam has a multi-year proven track record as a discovery services partner for the life science industry. Until now, Axxam has collaborated with over 50 international partners, ranging from small biotechs to big pharma, agrochemical, fragrance and flavour companies, and a growing network of research institutions and academic groups.

 

For more information, please visit our website.

 

Project Leader: Dr. Loredana Redaelli

Life and Brain

Life & Brain GmbH

LIFE & BRAIN is the commercial hub of the Medial Center at the University of Bonn. As an SME founded in 2002 our mission is to discover and develop novel strategies for the diagnosis and therapy of nervous system disorders. Integrating a unique set of expertise in Genomics, Transgenics, Cellomics and NeuroCognition, we aim at delivering the next generation of products for disease modeling and prediction, compound development and tissue regeneration.

LIFE & BRAIN Cellomics offers authentic cellular disease models that contribute to drug discovery and regenerative medicine. A particular focus of the Cellomics Platform is the controlled differentiation of human pluripotent stem cells into defined cell types of the nervous system. We offer custom development services for phenotyping and assay development for research purposes and drug screening. Extensive cell culture automation enables robust production of hiPS cell-based disease models on industrial scale and standards. Genomic quality control service can be provided via our Genomics department.

 

For more information, please visit our homepage.

 

Project Leader: Oliver Bruestle (CEO)
Project Leader: Mona Mathews (Postdoctoral Reserach Fellow, Cellomics)

Home
Menu
Top
 

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115976. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA companies.

Social Media

PHAGO by Twitter PHAGO by LinkedIn

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115976. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA companies.